These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23037740)

  • 21. [Bortezomib plus dexamethasone treatment followed by reduced-intensity allogeneic stem cell transplantation for multiple myeloma refractory to high-dose chemotherapy with autologous transplantation].
    Hayashi T; Yasui H; Kawakami K; Ikeda H; Takahashi F; Kobayashi T; Nishimura S; Ishida T; Imai K; Shinomura Y
    Rinsho Ketsueki; 2011 Mar; 52(3):136-41. PubMed ID: 21471701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Trends in development of novel therapeutic agents for multiple myeloma].
    Kuroda J
    Rinsho Ketsueki; 2012 Oct; 53(10):1699-708. PubMed ID: 23037742
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeted treatments to improve stem cell outcome: old and new drugs.
    Raab MS; Breitkreutz I; Anderson KC
    Bone Marrow Transplant; 2007 Dec; 40(12):1129-37. PubMed ID: 17768392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Progress in the study of autologous hematopoietic stem cell transplantation therapy of multiple myeloma].
    Zhang M; Son K
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):331-3. PubMed ID: 11243115
    [No Abstract]   [Full Text] [Related]  

  • 25. Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?
    van Rhee F
    Nat Clin Pract Oncol; 2008 Feb; 5(2):70-1. PubMed ID: 17984985
    [No Abstract]   [Full Text] [Related]  

  • 26. [Role of interferon in the treatment of multiple myeloma].
    Shimazaki C
    Nihon Rinsho; 2006 Jul; 64(7):1291-6. PubMed ID: 16838647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of autologous stem cell transplantation in the management of multiple myeloma.
    Fermand JP; Brechignac S
    Pathol Biol (Paris); 1999 Feb; 47(2):199-202. PubMed ID: 10192889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support.
    Iversen PO; Wisløff F; Gulbrandsen N
    Clin Nutr; 2010 Aug; 29(4):488-91. PubMed ID: 20044183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma].
    García Laraña J; Díaz Mediavilla J; Martínez R; Lahuerta JJ; Alegre A; Odriozola J; Sureda A; San Miguel J; De la Rubia J; Escudero A; Conde E; Bladé J; Cabrera R; Gastearena J; Besalduch J; Vidal MJ; Hernández F; Rifon J; Leon A; Mataix R; Parody R; Moraleda JM; Solano C; de Pablos JM; Sánchez JJ
    Sangre (Barc); 1997 Apr; 42 Suppl 1():38-41. PubMed ID: 9381300
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review.
    Hahn T; Wingard JR; Anderson KC; Bensinger WI; Berenson JR; Brozeit G; Carver JR; Kyle RA; McCarthy PL
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):4-37. PubMed ID: 12533739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel approaches in myeloma therapy.
    Munshi NC; Barlogie B; Desikan KR; Wilson C
    Semin Oncol; 1999 Oct; 26(5 Suppl 13):28-34. PubMed ID: 10528892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of high-dose therapy with autologous stem cell support in the era of novel agents.
    Attal M; Harousseau JL
    Semin Hematol; 2009 Apr; 46(2):127-32. PubMed ID: 19389496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple myeloma: a new treatment paradigm.
    ONS News; 2004; 19(9 Suppl):79-80. PubMed ID: 15478600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of allogeneic stem cell transplantation in multiple myeloma.
    Thomson KJ; Peggs KS
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):455-64. PubMed ID: 16001953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New strategies in transplantation therapy.
    Harousseau JL
    Oncology (Williston Park); 2004 Nov; 18(13):1614-5, 1617. PubMed ID: 15648294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of multiple myeloma: 2009 update.
    Prescrire Int; 2009 Dec; 18(104):263-6. PubMed ID: 20025098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern treatment options for elderly patients with multiple myeloma.
    Görner M; Späth-Schwalbe E;
    Onkologie; 2008 Jun; 31(6):335-42. PubMed ID: 18547977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple myeloma: a tailored therapy for elderly patients.
    Pileri A; Palumbo A; Boccadoro M
    Hematol Oncol; 1993; 11 Suppl 1():67-72. PubMed ID: 8486344
    [No Abstract]   [Full Text] [Related]  

  • 39. [Multiple myeloma].
    Ozaki S
    Rinsho Ketsueki; 2013 Jan; 54(1):89-99. PubMed ID: 23391652
    [No Abstract]   [Full Text] [Related]  

  • 40. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial.
    Kim HJ; Yoon SS; Lee DS; Sohn SK; Eom HS; Lee JL; Chung JS; Kim K; Suh C; Won JH; Kim JS; Park JS; Kang HJ; Seong CM; Kim CS; Lee SJ; Lee JH
    Ann Hematol; 2012 Feb; 91(2):249-56. PubMed ID: 21789621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.